---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-016426"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:07:08.771990+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aprea Therapeutics updates corporate presentation slide deck; no specific changes disclosed

## Summary
- Filed corporate presentation slide deck dated October 2023; title indicates focus on precision oncology and synthetic lethality.
- No quantitative updates (e.g., financial results, clinical data) disclosed in the filing or the provided exhibit excerpt.
- Given the absence of specific changes, materiality of this update appears low.

## SEC filing metadata
- accession: 0001558370-23-016426
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/0001558370-23-016426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/apre-20231013x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-016426
- JSON: https://secwatch.observer/filing/0001558370-23-016426.json
- Plain text: https://secwatch.observer/filing/0001558370-23-016426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.